OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer
Yang Liu, Wei Xu, Mingxue Li, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 4, pp. 1438-1466
Open Access | Times Cited: 13

Showing 13 citing articles:

Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 47

Revealing the responses of sludge characteristics and microbial metabolic pathways to polyvinyl chloride microplastics in an AnSBR-ASBR system
Yiying Lu, Junjian Li, Kaiyi Wang, et al.
Journal of environmental chemical engineering (2025), pp. 115517-115517
Closed Access

PepGAT, a chitinase-derived peptide, alters the proteomic profile of colorectal cancer cells and perturbs pathways involved in cancer survival
Pedro F.N. Souza, Elmer Adilson Espino Zelaya, Emerson Lucena da Silva, et al.
International Journal of Biological Macromolecules (2025) Vol. 299, pp. 140204-140204
Closed Access

Reviewing the IDH1 Mutation‐Mediated Mechanism of Drug Resistance and Revisiting Its Overcoming Strategies
Yifan Wang, Hailong Bai, Aixin Wang, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 4
Closed Access

Discovery of novel natural-product-derived mutant isocitrate dehydrogenases 1 inhibitors: Structure-based virtual screening, biological evaluation and structure-activity relationship study
Tieling Xu, Junya Yang, Dong‐Sheng Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116610-116610
Closed Access | Times Cited: 3

Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment
Alina L. Capatina, Jodie R. Malcolm, Jack Stenning, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2

Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway
Cheng Zhang, Jiaojiao Yu, Chen Yang, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 726
Closed Access | Times Cited: 6

Identification of ALDOB as a novel prognostic biomarker in kidney clear cell renal cell carcinoma
Xiaoyang Li, You-Yao Xu, Senyan Wu, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29368-e29368
Open Access | Times Cited: 1

Molecular confirmation that fibrocartilaginous dysplasia is a variant of fibrous dysplasia
Juan Zhou, Xuling Su, Dingjun Hu, et al.
Journal of Clinical Pathology (2024), pp. jcp-209626
Closed Access | Times Cited: 1

3D-QSAR, Scaffold Hopping, Virtual Screening, and Molecular Dynamics Simulations of Pyridin-2-one as mIDH1 Inhibitors
Yifan Wang, Shunjiang Jia, Fan Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7434-7434
Open Access | Times Cited: 1

The development of a hiPSC-based platform to identify tissue-dependencies of IDH1 R132H
Nargis Mehjardi, Jacqueline Keßler, Ahmed Yousuf Sanin, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access

The development of a hiPSC-based platform to identify tissue-dependencies of IDH1 R132H
Ulf D. Kahlert, Nargis Mehjardi, Ahmed Sanin, et al.
Research Square (Research Square) (2023)
Open Access

Page 1

Scroll to top